Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test
- PMID: 34170555
- PMCID: PMC8426666
- DOI: 10.1002/jmv.27153
Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test
Abstract
A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse-transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS® SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE® SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79 were negative according to RT-qPCR. Consistent dose-dependent detection with VITROS® assay was successfully achieved when using nasopharyngeal swab specimens with Ct values of 32.0 or lesser, whereas the CLEIA-based LUMIPULSE® assay was able to detect lower viral loads compared with the VITROS® assay. Our results show that the performance of the VITROS® assay was satisfactory for the diagnosis of contagious COVID-19 patients in the clinical setting. Highlights The performance of the VITROS® SARS-CoV-2 Antigen Test was sufficient for the diagnosis of contagious COVID-19. This test showed high sensitivity and specificity in the detection of SARS-CoV-2 in samples with a Ct value of 32 or less.
Keywords: CLEIA; COVID-19; RT-qPCR; SARS-CoV-2; nasopharyngeal swab.
© 2021 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures

Similar articles
-
Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.Int J Infect Dis. 2021 Apr;105:391-396. doi: 10.1016/j.ijid.2021.02.098. Epub 2021 Feb 26. Int J Infect Dis. 2021. PMID: 33647511 Free PMC article.
-
Utility of Antigen-Based Rapid Diagnostic Test for Detection of SARS-CoV-2 Virus in Routine Hospital Settings.Lab Med. 2021 Nov 2;52(6):e154-e158. doi: 10.1093/labmed/lmab033. Lab Med. 2021. PMID: 33928384 Free PMC article.
-
Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays.J Med Virol. 2021 Dec;93(12):6512-6518. doi: 10.1002/jmv.27186. Epub 2021 Jul 28. J Med Virol. 2021. PMID: 34241912 Free PMC article.
-
Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses.Curr Med Res Opin. 2021 Feb;37(2):207-217. doi: 10.1080/03007995.2020.1862532. Epub 2020 Dec 26. Curr Med Res Opin. 2021. PMID: 33306409 Free PMC article. Review.
-
Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and meta-analysis.J Med Virol. 2021 Feb;93(2):719-725. doi: 10.1002/jmv.26349. Epub 2020 Aug 2. J Med Virol. 2021. PMID: 32706393 Free PMC article.
Cited by
-
Diagnostic Performance of Automated SARS-CoV-2 Antigen Assay in Nasal Swab during COVID-19 Vaccination Campaign.Diagnostics (Basel). 2021 Nov 15;11(11):2110. doi: 10.3390/diagnostics11112110. Diagnostics (Basel). 2021. PMID: 34829457 Free PMC article.
-
Performance of Antigen Detection Tests for SARS-CoV-2: A Systematic Review and Meta-Analysis.Diagnostics (Basel). 2022 Jun 4;12(6):1388. doi: 10.3390/diagnostics12061388. Diagnostics (Basel). 2022. PMID: 35741198 Free PMC article. Review.
-
Clinical accuracy of instrument-based SARS-CoV-2 antigen diagnostic tests: a systematic review and meta-analysis.Virol J. 2024 Apr 29;21(1):99. doi: 10.1186/s12985-024-02371-5. Virol J. 2024. PMID: 38685117 Free PMC article.
-
Critical literature review and pooled analysis of diagnostic accuracy of Ortho VITROS SARS-CoV-2 antigen test for diagnosing acute SARS-CoV-2 infections.J Med Biochem. 2022 Oct 15;41(4):540-548. doi: 10.5937/jomb0-36107. J Med Biochem. 2022. PMID: 36381069 Free PMC article.
-
Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages.Med Microbiol Immunol. 2023 Oct;212(5):307-322. doi: 10.1007/s00430-023-00774-9. Epub 2023 Aug 10. Med Microbiol Immunol. 2023. PMID: 37561226 Free PMC article.
References
-
- Tegally H, Wilkinson E, Giovanetti M, et al. Emergence and rapid spread of a new severe acute respiratory syndrome‐related coronavirus 2 (SARS‐CoV‐2) lineage with multiple spike mutations in South Africa. medRxiv. 2020. 10.1101/2020.12.21.20248640 - DOI
-
- Centers for Disease Control and Prevention . Duration of isolation and precautions for adults with COVID‐19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html. Accessed June 29, 2021
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous